BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|July 26, 2016
- July 2016 Digestive Health
- Volume 82
- Issue 7
2016 Next-Generation Pharmacist Awards: Meet the Finalists!
Advertisement
The Next-Generation Pharmacist® Awards is a national program that salutes pharmacy professionals who are defining the industry’s future. Now in its seventh year, Pharmacy Times and Parata Systems, co-founders of this prestigious awards program, recognize pharmacy leaders across a wide range of practice settings who embody the innovation and inspiration in pharmacy and the future vision of this profession.
Visit
Meet the Finalists
Articles in this issue
about 10 years ago
2016 Lifetime Leadership Finalistsabout 10 years ago
2016 Specialty Pharmacist of the Year Finalistsabout 10 years ago
2016 Technology Innovator of the Year Finalistsabout 10 years ago
2016 Technician of the Year Finalistsabout 10 years ago
2016 Rising Star of the Year Finalistsabout 10 years ago
2016 Patient Care Provider of the Year Finalistsabout 10 years ago
Can You Read These Rxs? (July 2016)about 10 years ago
2016 Health-System Pharmacist of the Year Finalistsabout 10 years ago
2016 Civic Leader of the Year Finalistsabout 10 years ago
2016 Military Pharmacist of the Year FinalistsAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
2
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch
5